| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Departments of Pathology and Dermatology,* Dermatopathology Section, and the University of California San Francisco Comprehensive Cancer Center, University of California San Francisco, San Francisco, California
Melanoma and benign melanocytic nevi can overlap significantly in their histopathological presentation and misdiagnoses are common. To determine whether genetic criteria can be of diagnostic help we determined DNA copy number changes in 186 melanocytic tumors (132 melanomas and 54 benign nevi) using comparative genomic hybridization. We found highly significant differences between melanomas and nevi. Whereas 127 (96.2%) of the melanomas had some form of chromosomal aberration, only 7 (13.0%) of the benign nevi cases had aberrations. All seven cases with aberrations were Spitz nevi, in six of which the aberration was an isolated gain involving the entire short arm of chromosome 11. This aberration was not observed in any of the 132 melanomas. We also analyzed the 132 melanomas for genetic differences depending on anatomical site, Clark’s histogenetic type, and sun-exposure pattern. We show that melanomas on acral sites have significantly more aberrations involving chromosomes 5p, 11q, 12q, and 15, as well as focused gene amplifications. Melanomas classified as lentigo maligna melanomas or as occurring on severely sun-damaged skin showed markedly more frequent losses of chromosomes 17p and 13q. This study shows a pattern of chromosomal aberration in melanoma that is distinct from melanocytic nevi and should be further evaluated as a diagnostic test for melanocytic lesions that are now ambiguous. In addition, we show marked differences in the genetic make-up of melanomas that depend on anatomical location and sun-exposure pattern indicating that potential therapeutic targets might vary among melanoma types.
This article has been cited by other articles:
 |
|
 |
|
  Y. Cui, M. K. Borysova, J. O. Johnson, and T. M. Guadagno Oncogenic B-RafV600E Induces Spindle Abnormalities, Supernumerary Centrosomes, and Aneuploidy in Human Melanocytic Cells Cancer Res., January 15, 2010; 70(2): 675 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hinshaw Use of Genetic Tools to Control Tumor Margins in Melanoma Arch Dermatol, April 1, 2009; 145(4): 475 - 477. [Full Text] [PDF]
|
|
|
|
|
|
P. Gerami, J. Guitart, M. Martini, J. D. Wayne, and T. Kuzel Cyclin D1 Homogeneous Staining Regions by Fluorescent In Situ Hybridization: A Possible Indicator of Aggressive Behavior in Melanomas Arch Dermatol, September 1, 2008; 144(9): 1235 - 1236. [Full Text] [PDF]
|
|
|
|
|
|
T. N. Helm and K. F. Helm More Evidence for a New Melanoma Paradigm Arch Dermatol, July 1, 2008; 144(7): 946 - 947. [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Kreizenbeck, A. J. Berger, A. Subtil, D. L. Rimm, and B. E. Gould Rothberg Prognostic Significance of Cadherin-Based Adhesion Molecules in Cutaneous Malignant Melanoma Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 949 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Delmas, F. Beermann, S. Martinozzi, S. Carreira, J. Ackermann, M. Kumasaka, L. Denat, J. Goodall, F. Luciani, A. Viros, et al. beta-Catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development Genes & Dev., November 15, 2007; 21(22): 2923 - 2935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Torisu-Itakura, J. H. Lee, R. P. Scheri, Y. Huynh, X. Ye, R. Essner, and D. L. Morton Molecular Characterization of Inflammatory Genes in Sentinel and Nonsentinel Nodes in Melanoma Clin. Cancer Res., June 1, 2007; 13(11): 3125 - 3132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stark and N. Hayward Genome-Wide Loss of Heterozygosity and Copy Number Analysis in Melanoma Using High-Density Single-Nucleotide Polymorphism Arrays Cancer Res., March 15, 2007; 67(6): 2632 - 2642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C Santos, M Zielenska, M Prasad, and J A Squire Chromosome 6p amplification and cancer progression J. Clin. Pathol., January 1, 2007; 60(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Elder Pathology of melanoma. Clin. Cancer Res., April 1, 2006; 12(7): 2308s - 2311s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Curtin, J. Fridlyand, T. Kageshita, H. N. Patel, K. J. Busam, H. Kutzner, K.-H. Cho, S. Aiba, E.-B. Brocker, P. E. LeBoit, et al. Distinct Sets of Genetic Alterations in Melanoma N. Engl. J. Med., November 17, 2005; 353(20): 2135 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ikuta, T. Nakatsura, T. Kageshita, S. Fukushima, S. Ito, K. Wakamatsu, H. Baba, and Y. Nishimura Highly Sensitive Detection of Melanoma at an Early Stage Based on the Increased Serum Secreted Protein Acidic and Rich in Cysteine and Glypican-3 Levels Clin. Cancer Res., November 15, 2005; 11(22): 8079 - 8088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yamaura, M. Takata, A. Miyazaki, and T. Saida Specific Dermoscopy Patterns and Amplifications of the Cyclin D1 Gene to Define Histopathologically Unrecognizable Early Lesions of Acral Melanoma In Situ Arch Dermatol, November 1, 2005; 141(11): 1413 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ulmer, J. R. Fischer, S. Schanz, K. Sotlar, H. Breuninger, K. Dietz, G. Fierlbeck, and C. A. Klein Detection of Melanoma Cells Displaying Multiple Genomic Changes in Histopathologically Negative Sentinel Lymph Nodes Clin. Cancer Res., August 1, 2005; 11(15): 5425 - 5432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hoek, D. L. Rimm, K. R. Williams, H. Zhao, S. Ariyan, A. Lin, H. M. Kluger, A. J. Berger, E. Cheng, E. S. Trombetta, et al. Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas Cancer Res., August 1, 2004; 64(15): 5270 - 5282. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
